dialine low calcium peritoneal dialysis solution with 1.5 % dextrose
teva medical ltd - calcium chloride; glucose hydrous; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - glucose hydrous 1.5 g / 100 ml; calcium chloride 18.3 mg / 100 ml; sodium chloride 538 mg / 100 ml; lactic acid as sodium 448 mg / 100 ml; magnesium chloride 5.08 mg / 100 ml - combinations of electrolytes - combinations of electrolytes - for use in chronic renal failure patients being maintained in peritoneal dialysis.
dialine low calcium peritoneal dialysis solution with 2.5 % dextrose
teva medical ltd - calcium chloride; glucose hydrous; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - glucose hydrous 2.5 g / 100 ml; calcium chloride 18.3 mg / 100 ml; sodium chloride 538 mg / 100 ml; lactic acid as sodium 448 mg / 100 ml; magnesium chloride 5.08 mg / 100 ml - combinations of electrolytes - combinations of electrolytes - for use in chronic renal failure patients being maintained in peritoneal dialysis.
dialine low calcium peritoneal dialysis solution with 4.25 % dexstrose
teva medical ltd - calcium chloride; glucose hydrous; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - glucose hydrous 4.25 g / 100 ml; magnesium chloride 5.08 mg / 100 ml; sodium chloride 538 mg / 100 ml; lactic acid as sodium 448 mg / 100 ml; calcium chloride 18.3 mg / 100 ml - electrolytes in combination with other drugs - electrolytes in combination with other drugs - for use in chronic renal failure patient being maintained in peritoneal dialysis.
sodium iodide (i-131) capsule t
isorad ltd, israel - iodine sodium - capsules - iodine sodium 37 mbq - sodium iodide (131i) - sodium iodide (131i) - treatment of graves disease, toxic multinodular goite or autonomous nodules.treatment of papillary and follicular thyroid carcinoma including metastatic disease. sodium iodide (i-131) therapy is often combined with surgical intervention and with antithyroid medications.
calcium folinate 10mg/ml injection (5ml)
hospira uk limited - calcium folinate - solution for injection - calcium folinate 10 mg/ml - all other therapeutic products
calcium folinate solution for injection 10mg/ml (10ml)
hospira uk limited - calcium folinate - solution for injection - calcium folinate 10 mg/ml - all other therapeutic products
calcium folinate solution for injection 10mg/ml (30ml)
hospira uk limited - calcium folinate - solution for injection - calcium folinate 10 mg/ml - all other therapeutic products
calcium acetate capsule
hikma pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.
calcium acetate tablet
camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a c
calcium acetate capsule
remedyrepack inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and d